Sorafenib induces cathepsin B-mediated apoptosis of bladder cancer cells by regulating the Akt/PTEN pathway. The Akt inhibitor, perifosine, enhances the sorafenib-induced cytotoxicity against bladder cancer cells.

Abstract

Sorafenib, a tyrosine kinase inhibitor, has been demonstrated to exert anti-tumor effects. However, the molecular mechanisms underlying its effects on bladder cancer remain unknown.Here, we evaluated the mechanisms responsible for the sorafenib-induced anti-tumor effects on 5637 and T24 bladder cancer cells. We demonstrated that sorafenib reduces cell viability, stimulates lysosome permeabilization and induces apoptosis of bladder cancer cells. These effects are dependent by the activation of cathepsin B released from lysosomes. The sorafenib-increased cathepsin B activity induced the proteolysis of Bid into tBid that stimulates the intrinsic pathway of apoptosis characterized by mitochondrial membrane depolarization, oxygen radical generation and cytochrome c release. Moreover, we found that cathepsin B enzymatic activity, induced by sorafenib, is dependent on its dephosphorylation via PTEN activation and Akt inactivation. Pretreatment with orthovanadate rescued bladder cancer cells from apoptosis. In addition, the Akt inhibitor perifosine increased the sensitivity of bladder cancer cells to sorafenib-induced cytotoxicity.Overall, our results show that apoptotic cell death induced by sorafenib in bladder cancer cells is dependent on cathepsin B activity and involved PTEN and Akt signaling pathways. The Akt inhibitor perifosine increased the cytotoxic effects of sorafenib in bladder cancer cells.

Bosutinib, an SRC inhibitor, induces caspase‐independent cell death associated with permeabilization of lysosomal membranes in melanoma cells

“…However, no changes were found in its expression level between the cells treated with DMSO and Bosu (data not shown). More recently, other tyrosine kinase inhibitors (TKIs), such as sorafenib and gefitinib, have been reported to induce LMP or block autophagy flux, resulting in the cell death; although their mechanisms are slightly different from our current findings . Altogether, recent findings including this study indicate that TKIs might exhibit anti‐cancer effects by targeting lysosomes, in addition to their originally recognized target molecules, in cancer cells.…”

Dysfunction of Membrane Trafficking Leads to Ischemia-Reperfusion Injury After Transient Cerebral Ischemia

“…Several recent studies indicate that a vacuole-like structure between mitochondrial inner and outer membranes is a distinctive morphological sign of MOMP [54,55]. This was observed by an immunogold EM study showing that mitochondrial outer membrane was associated with clusters of immunogold-labeled ubiquitinated proteins (Fig.…”

NRBP2 Overexpression Increases the Chemosensitivity of Hepatocellular Carcinoma Cells via Akt Signaling

“…To further ascertain the relationship between NRBP2 expression and chemoresistance, hepatocellular carcinoma cells were incubated with different doses of sorafenib. Sorafenib could induce cancer cell apoptosis through the mitochondrial pathway, and cleavage of PARP is one of the early markers of chemotherapyinduced apoptosis (26,27). As shown in Fig.…”